Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Gemcitabine, Cisplatin, and Sunitinib for Bladder Cancer
NCT00859339Phase 2Terminated
- Start
- Mar 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sunitinib in bladder carcinoma. Started Mar 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
bladder carcinoma
Beyond the preview
Go deeper on NCT00859339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859339.